138. 神経細胞移動異常症 Nerve cell migration disorder Clinical trials / Disease details

臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 1) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 106

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05577754 (ClinicalTrials.gov)	November 28, 2022	10/10/2022	Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Meg ...	A Phase II Double-blind Multi-center, Placebo-controlled Trial, to Assess the Efficacy and Safety of ...	Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)	Drug: Alpelisib (BYL719);Drug: Matching placebo;Procedure: Optional lumbar puncture	Centre Hospitalier Universitaire Dijon	NULL	Recruiting	2 Years	40 Years	All	16	Phase 2	France

First Previous1Next Last